FDA Import Refusal SCS-0909314-8/11/1 — Glaxosmithkline Consumer Healthcare
The FDA refused shipment SCS-0909314-8/11/1 from Glaxosmithkline Consumer Healthcare (Australia) on Sep 13, 2018. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 13, 2018
- Country
- Australia
- Product Category
- Drugs and Biologics
- Product Code
- 62GAY18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
- Charges
- 75